Literature DB >> 14990694

Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.

Tetsuro Shimakami1, Makoto Hijikata, Hong Luo, Yuan Yuan Ma, Shuichi Kaneko, Kunitada Shimotohno, Seishi Murakami.   

Abstract

Hepatitis C virus (HCV) NS5A has been reported to be important for the establishment of replication by adaptive mutations or localization, although its role in viral replication remains unclear. It was previously reported that NS5A interacts with NS5B via two regions of NS5A in the isolate JK-1 and modulates the activity of NS5B RdRp (Y. Shirota et al., J. Biol. Chem., 277:11149-11155, 2002), but the biological significance of this interaction has not been determined. In this study, we addressed the effect of this interaction on HCV RNA replication with an HCV replicon system derived from the isolate M1LE (H. Kishine et al., Biochem. Biophys. Res. Commun., 293:993-999, 2002). We constructed three internal deletion mutants, M1LE/5Adel-1 and M1LE/5Adel-2, each encoding NS5A which cannot bind NS5B, and M1LE/5Adel-3, encoding NS5A that can bind NS5B. After transfection into Huh-7 cells, M1LE/5Adel-3 was replication competent, but both M1LE/5Adel-1 and M1LE/5Adel-2 were not. Next we prepared 20 alanine-substituted clustered mutants within both NS5B-binding regions and examined the effect of these mutants on HCV RNA replication. Only 5 of the 20 mutants were replication competent. Subsequently, we introduced a point mutation, S225P, a deletion of S229, or S232I into NS5A and prepared cured Huh-7 cells that were cured of RNA replication by alpha interferon. Finally, with these point mutations and cured cells, we established a highly improved replicon system. In this system, only the same five mutants were replication competent. These results strongly suggest that the interaction between NS5A and NS5B is critical for HCV RNA replication in the HCV replicon system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990694      PMCID: PMC353754          DOI: 10.1128/jvi.78.6.2738-2748.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus.

Authors:  M Hijikata; H Mizushima; Y Tanji; Y Komoda; Y Hirowatari; T Akagi; N Kato; K Kimura; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

2.  Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

3.  Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone.

Authors:  M Yanagi; M St Claire; S U Emerson; R H Purcell; J Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling.

Authors:  S L Tan; H Nakao; Y He; S Vijaysri; P Neddermann; B L Jacobs; B J Mayer; M G Katze
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

6.  Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection.

Authors:  N Kato; T Nakazawa; T Mizutani; K Shimotohno
Journal:  Biochem Biophys Res Commun       Date:  1995-01-26       Impact factor: 3.575

7.  Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.

Authors:  N Kato; Y Ootsuyama; H Sekiya; S Ohkoshi; T Nakazawa; M Hijikata; K Shimotohno
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.

Authors:  V Lohmann; F Körner; J Koch; U Herian; L Theilmann; R Bartenschlager
Journal:  Science       Date:  1999-07-02       Impact factor: 47.728

9.  Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli.

Authors:  E Ferrari; J Wright-Minogue; J W Fang; B M Baroudy; J Y Lau; Z Hong
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  S E Behrens; L Tomei; R De Francesco
Journal:  EMBO J       Date:  1996-01-02       Impact factor: 11.598

View more
  39 in total

Review 1.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

3.  Synergy of small molecular inhibitors of hepatitis C virus replication directed at multiple viral targets.

Authors:  David L Wyles; Kelly A Kaihara; Florin Vaida; Robert T Schooley
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  The intraviral protein interaction network of hepatitis C virus.

Authors:  Nicole Hagen; Karen Bayer; Kathrin Rösch; Michael Schindler
Journal:  Mol Cell Proteomics       Date:  2014-05-05       Impact factor: 5.911

5.  Interferon-beta is activated by hepatitis C virus NS5B and inhibited by NS4A, NS4B, and NS5A.

Authors:  Masaru Moriyama; Naoya Kato; Motoyuki Otsuka; Run-Xuan Shao; Hiroyoshi Taniguchi; Takao Kawabe; Masao Omata
Journal:  Hepatol Int       Date:  2007-06       Impact factor: 6.047

6.  Ribavirin resistance in hepatitis C virus replicon-containing cell lines conferred by changes in the cell line or mutations in the replicon RNA.

Authors:  Julie K Pfeiffer; Karla Kirkegaard
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase.

Authors:  Melissanne de Wispelaere; Amy J LaCroix; Priscilla L Yang
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

8.  The Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific Manner.

Authors:  Elizabeth M Quezada; Caroline M Kane
Journal:  Open Biochem J       Date:  2009-04-20

9.  Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis.

Authors:  Shigeru Ohtsuru; Yoshihide Ueda; Hiroyuki Marusawa; Tadashi Inuzuka; Norihiro Nishijima; Akihiro Nasu; Kazuharu Shimizu; Kaoru Koike; Shinji Uemoto; Tsutomu Chiba
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

Review 10.  Hepatitis C virus proteins.

Authors:  Jean Dubuisson
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.